DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Pasi KJ, Lissitchkov T, Georgiev P. et al.
Fitusiran, an investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia: Interim results from a phase 2 extension study in patients with hemophilia A or B with and without inhibitors.
Res Pract Thromb Haemost 2017;
1 (01) 25-26
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.